KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:EARS
Delisted

Auris Medical Holding AG Stock Price (Quote)

$0.750
-0.0010 (-0.133%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.680 $1.00 Friday, 27th May 2022 EARS stock ended at $0.750. This is 0.133% less than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 10.68% from a day low at $0.740 to a day high of $0.82.
90 days $0.635 $2.14
52 weeks $0.635 $4.58

Historical Auris Medical Holding AG prices

Date Open High Low Close Volume
Feb 29, 2016 $4.71 $4.96 $4.70 $4.75 148 500
Feb 26, 2016 $4.77 $4.83 $4.58 $4.75 161 600
Feb 25, 2016 $4.40 $4.77 $4.36 $4.68 300 800
Feb 24, 2016 $4.24 $4.45 $4.17 $4.43 46 900
Feb 23, 2016 $4.11 $4.43 $4.11 $4.29 70 700
Feb 22, 2016 $4.32 $4.32 $4.15 $4.22 48 800
Feb 19, 2016 $4.28 $4.37 $4.11 $4.29 41 500
Feb 18, 2016 $4.47 $4.56 $4.21 $4.33 42 600
Feb 17, 2016 $4.52 $4.54 $4.32 $4.43 86 100
Feb 16, 2016 $4.46 $4.62 $4.42 $4.53 156 100
Feb 12, 2016 $4.35 $4.43 $4.08 $4.35 103 600
Feb 11, 2016 $4.10 $4.25 $3.96 $4.20 84 100
Feb 10, 2016 $4.19 $4.22 $4.00 $4.09 84 500
Feb 09, 2016 $4.20 $4.54 $4.13 $4.21 161 900
Feb 08, 2016 $4.15 $4.28 $3.99 $4.22 196 700
Feb 05, 2016 $4.15 $4.28 $3.93 $4.07 99 500
Feb 04, 2016 $4.07 $4.35 $3.95 $4.19 137 800
Feb 03, 2016 $4.10 $4.10 $3.80 $3.91 151 200
Feb 02, 2016 $4.23 $4.35 $3.99 $4.05 97 200
Feb 01, 2016 $4.45 $4.45 $4.10 $4.29 117 600
Jan 29, 2016 $4.50 $4.66 $4.33 $4.48 148 700
Jan 28, 2016 $4.68 $4.69 $4.39 $4.50 224 700
Jan 27, 2016 $4.42 $5.23 $4.38 $4.72 906 900
Jan 26, 2016 $4.20 $4.48 $4.20 $4.39 351 400
Jan 25, 2016 $4.17 $4.49 $4.14 $4.22 133 100
Click to get the best stock tips daily for free!

About Auris Medical Holding AG

Auris Medical Holding AG Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical development for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss; and other pre-clinical stage products comprising AM-102 and AM-123. It has... EARS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT